Demographic |
Age, yr, median (IQR) | 44 (30.5–59.5) |
Male sex | 33 (66) |
Days from symptom onset to health care assessment, median (IQR) | 3 (1.5–5.0) |
Travel within 14 d of symptom onset† | 26 (52) |
Austria | 3 |
Canada (within country) | 2 |
Cayman Islands | 1 |
Colombia | 1 |
Dominican Republic | 1 |
Egypt | 2 |
England | 1 |
Germany | 1 |
Iran | 3 |
Japan | 1 |
Peru | 2 |
Switzerland | 1 |
United Arab Emirates | 2 |
United States | 10 |
Health care worker | 17 (34) |
Community acquisition | 9 |
Travel within 14 d of symptom onset | 8 |
Comorbidities |
Asthma | 3 (6) |
Cardiac disease | 1 (2) |
Chronic hematologic disease | 2 (4) |
Chronic kidney disease | 2 (4) |
Chronic lung disease | 1 (2) |
Chronic neurologic disease | 1 (2) |
Diabetes | 3 (6) |
HIV infection | 0 (0) |
Hypertension | 11 (22) |
Malignant disease | 5 (10) |
Malnutrition | 0 (0) |
Moderate to severe liver disease | 0 (0) |
Obesity | 1 (2) |
Rheumatic disorder | 1 (2) |
Smoking | 5 (10) |
Presenting symptoms |
Abdominal pain | 8 (16) |
Adenopathy | 0 (0) |
Anorexia | 21 (42) |
Arthralgia | 5 (10) |
Chest pain | 7 (14) |
Chills/rigors | 18 (36) |
Confusion | 1 (2) |
Conjunctivitis | 3 (6) |
Cough | 34 (68) |
Depression and anxiety | 9 (18) |
Diarrhea | 15 (30) |
Dyspnea | 10 (20) |
Fatigue/malaise | 32 (64) |
Fever | 19 (38) |
Headache | 22 (44) |
Hemoptysis | 0 (0) |
Insomnia | 13 (26) |
Myalgia | 21 (42) |
Nausea and vomiting | 10 (20) |
Otalgia | 5 (10) |
Pharyngitis | 19 (38) |
Rash | 0 (0) |
Rhinorrhea | 13 (26) |
Sputum production | 16 (32) |
Wheezing | 2 (4) |
Investigations |
Complete blood count | 13 (26) |
Leukocyte count × 109/L, median | 4.9 |
Lymphocyte count × 109/L, median | 0.9 |
Chest radiography | 15 (30) |
Abnormal findings | 11 |
Bilateral infiltrates | 7 |